Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicki A Morrison

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Blood|December 7, 2010
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLLSusan L Slager, Kari G Rabe, Sara J Achenbach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2010
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)Peter G Pappas, Barbara D Alexander, David R Andes, et al.
The Journal of Infectious Diseases|August 29, 2009
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccineAdriana Weinberg, Jane H Zhang, Michael N Oxman, et al.
Emerging Infectious Diseases|October 18, 2011
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006Benjamin J Park, Peter G Pappas, Kathleen A Wannemuehler, et al.
British Journal of Haematology|August 27, 2010
Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL familiesLynn R Goldin, Mark C Lanasa, Susan L Slager, et al.
Lancet (London, England)|December 20, 2015
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trialJohan A Maertens, Issam I Raad, Kieren A Marr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2010
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) DatabaseDimitrios P Kontoyiannis, Kieren A Marr, Benjamin J Park, et al.
American Journal of Hematology|October 23, 2015
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphomaMatthew J Maurer, Jean-Philippe Jais, Hervé Ghesquières, et al.
Journal of Geriatric Oncology|June 16, 2019
Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology, Araba Adjei, Jan C Buckner, et al.
Blood|June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSusan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Blood|December 7, 2010
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLLSusan L Slager, Kari G Rabe, Sara J Achenbach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2010
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)Peter G Pappas, Barbara D Alexander, David R Andes, et al.
The Journal of Infectious Diseases|August 29, 2009
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccineAdriana Weinberg, Jane H Zhang, Michael N Oxman, et al.
Emerging Infectious Diseases|October 18, 2011
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006Benjamin J Park, Peter G Pappas, Kathleen A Wannemuehler, et al.
British Journal of Haematology|August 27, 2010
Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL familiesLynn R Goldin, Mark C Lanasa, Susan L Slager, et al.
Lancet (London, England)|December 20, 2015
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trialJohan A Maertens, Issam I Raad, Kieren A Marr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2010
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) DatabaseDimitrios P Kontoyiannis, Kieren A Marr, Benjamin J Park, et al.
American Journal of Hematology|October 23, 2015
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphomaMatthew J Maurer, Jean-Philippe Jais, Hervé Ghesquières, et al.
Journal of Geriatric Oncology|June 16, 2019
Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology, Araba Adjei, Jan C Buckner, et al.
Blood|June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSusan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.
Pageof 9